Updated Management Protocol for Multisystem Inflammatory Syndrome in Children (MIS-C)

Area of Science:

• Pediatrics
• Infectious Diseases
• Immunology

Background:

• Multisystem inflammatory syndrome in children (MIS-C) is a rare but serious post-infectious complication of SARS-CoV-2.
• MIS-C commonly affects older children presenting with fever, multi-systemic involvement, and hyper-inflammation.
• Current MIS-C treatment protocols lack global uniformity, particularly in India.

Purpose of the Study:

• To propose a uniform management protocol for MIS-C.
• To enhance early identification and diagnosis of MIS-C in children.
• To stratify treatment based on disease severity and manage hyper-inflammation.

Main Methods:

• Review of existing evidence and recent guidelines on MIS-C management.
• Incorporation of clinical experience from treating MIS-C cases.
• Development of a standardized protocol for identification, diagnosis, and treatment stratification.

Main Results:

• The proposed protocol aims for high sensitivity in identifying MIS-C.
• It facilitates differentiation from other infectious or inflammatory conditions.
• It provides a framework for severity-based management of hyper-inflammatory syndrome.

Conclusions:

• A uniform management protocol is crucial for consistent and effective MIS-C care.
• Standardized approaches can improve patient outcomes by ensuring timely and appropriate interventions.
• Further research and guideline adherence are essential for optimal MIS-C management.